PlainRecalls
FDA Drug Moderate Class II Terminated

Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.

Reported: March 3, 2021 Initiated: November 19, 2020 #D-0270-2021

Product Description

Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.

Reason for Recall

CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.

Details

Recalling Firm
Areva Pharmaceuticals Inc
Units Affected
3287 vials
Distribution
Nationwide in the USA
Location
Georgetown, IN

Frequently Asked Questions

What product was recalled?
Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.. Recalled by Areva Pharmaceuticals Inc. Units affected: 3287 vials.
Why was this product recalled?
CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 3, 2021. Severity: Moderate. Recall number: D-0270-2021.